Home Industries Real Estate Eli Lilly buys another 31 acres in Kenosha County

Eli Lilly buys another 31 acres in Kenosha County

10121 136th Ave., Bristol

Indianapolis-based pharmaceutical giant Eli Lilly and Company has purchased 30.9 acres of vacant land to the north and to the south of the 323,930-square-foot industrial building that it recently acquired in the Village of Bristol, according to state records. The company paid $10.2 million for the land, according to the state real estate transfer filing. It

Already a subscriber? Log in

To continue reading this article ...

Subscribe to BizTimes today and get immediate access to our Insider-only content and much more.

Learn More and Subscribe Now
Andrew is the editor of BizTimes Milwaukee. He joined BizTimes in 2003, serving as managing editor and real estate reporter for 11 years. A University of Wisconsin-Madison graduate, he is a lifelong resident of the state. He lives in Muskego with his wife, Seng, their son, Zach, and their dog, Hokey. He is an avid sports fan and is a member of the Muskego Athletic Association board of directors.
Indianapolis-based pharmaceutical giant Eli Lilly and Company has purchased 30.9 acres of vacant land to the north and to the south of the 323,930-square-foot industrial building that it recently acquired in the Village of Bristol, according to state records. The company paid $10.2 million for the land, according to the state real estate transfer filing. It paid $40.8 million for the 323,930-square-foot building, located on a 21.6-acre site at 10121 136th Ave. in the Bristol Business Park. The building and the land was sold to Eli Lilly by an affiliate of Riverwoods, Illinois-based commercial real estate firm Janko Group. The property acquisitions by Eli Lilly in Bristol create a 52.5-acre site for the company, located northeast of 136th Avenue (County Highway U) and 104th Street (County Highway Q). The site provides room to expand the 323,930-square-foot building or add additional development. A spokesperson for Eli Lilly could not immediately be reached for comment. The site is also just west of the 100,000-square-foot former Nexus Pharmaceuticals manufacturing facility at 10300 128th Ave. in Pleasant Prairie, which Eli Lilly acquired earlier this year. In August the company disclosed that it paid $924.7 million, net of cash acquired, to the entities that owned the assets of the Nexus Pharmaceuticals facility. According to an Eli Lilly securities filing, the purchase price included $108.5 million for the property and equipment and $816.5 million for goodwill. Eli Lilly attributed the goodwill “to the synergies between the manufacturing capabilities of the site and our products as well as the assembled workforce of the site.” Eli Lilly said in April it would use the Nexus Pharmaceuticals plant to expand its global parenteral or injectable product manufacturing network. Nexus initially invested $100 million to open the plant in 2021. The Eli Lilly site in Bristol is also located just west of where Uline is building a 366,000-square-foot, three-story office building near its corporate headquarters complex in Pleasant Prairie. The building will be built a 44.8-acre site at 9900 128th Ave. in the Prairie Highlands Corporate Park. The facility could house up to 1,300 employees. Construction is expected to be completed by the spring of 2026.

Stay up-to-date with our free email newsletter

Keep up with the issues, companies and people that matter most to business in the Milwaukee metro area.

By subscribing you agree to our privacy policy.

No, thank you.
Exit mobile version